• Bago-Horvath Z, Schmid K, Rössler F, Nagy-Bojarszky K, Funovics P, Sulzbacher I. Impact of RANK signalling on survival and chemotherapy Response in osteosarcoma. Pathology. 2014;46:411-5. http://www.ncbi.nlm.nih.gov/pubmed/24842377
  • Müller S, Chen Y, Ginter T, Schäfer C, Buchwald M, Schmitz LM, Klitzsch J, Schütz A, Haitel A, Schmid K, Moriggl R, Kenner L, Friedrich K, Haan C, Petersen I, Heinzel T, Krämer OH. SIAH2 antagonizes TYK2-STAT3 signaling in lung carcinoma cells. Oncotarget. 2014;30:3184-96. http://www.ncbi.nlm.nih.gov/pubmed/24833526
  • Heidemann F, Schildt A, Schmid K, Bruns OT, Riecken K, Jung C, Ittrich H, Wicklein D, Reimer R, Fehse B, Heeren J, Lüers G, Schumacher U, Heine M. Selectins mediate small cell lung cancer systemic metastasis. PLoS One. 2014;9:e92327. http://www.ncbi.nlm.nih.gov/pubmed/24699516
  • Schröder C, Milde-Langosch K, Gebauer F, Schmid K, Mueller V, Wirtz RM, Meyer-Schwesinger C, Schlüter H, Sauter G, Schumacher U. Prognostic relevance of ubiquitin C-terminal hydrolase L1 (UCH-L1) mRNA and protein expression in breast cancer patients. J Cancer Res Clin Oncol. 2013;139:1745-55. http://www.ncbi.nlm.nih.gov/pubmed/23996067
  • Wunder T, Schmid K, Wicklein D, Groitl P, Dobner T, Lange T, Anders M, Schumacher U. Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infection. Cancer Gene Ther. 2013;20:25-32. http://www.ncbi.nlm.nih.gov/pubmed/23196273
  • Bago-Horvath Z, Sieghart W, Grusch M, Lackner A, Hayden H, Pirker C, Komina O, Węsierska-Gądek J, Haitel A, Filipits M, Berger W, Schmid K. Synergistic effects of erlotinib and everolimus on bronchial carcinoids and large-cell neuroendocrine carcinomas with activated EGFR/AKT/mTOR pathway. Neuroendocrinology. 2012;96(3):228-37. http://www.ncbi.nlm.nih.gov/pubmed/22378048
  • Losert A, Lötsch D, Lackner A, Koppensteiner H, Peter-Vörösmarty B, Steiner E, Holzmann K, Grunt T, Schmid K, Marian B, Grasl-Kraupp B, Schulte-Hermann R, Krupitza G, Berger W, Grusch M. The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Lett. 2012;319:164-72. http://www.ncbi.nlm.nih.gov/pubmed/22261339
  • Valencak J, Schmid K, Trautinger F, Wallnöfer W, Muellauer L, Soleiman A, Knobler R, Haitel A, Pehamberger H, Raderer M. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas. J Dermatol Sci. 2011;64:185-90 http://www.ncbi.nlm.nih.gov/pubmed/21937200
  • Windhorst S, Kalinina T, Schmid K, Blechner C, Kriebitzsch N, Hinsch R, Chang L, Herich L, Schumacher U, Mayr GW. Functional role of inositol-1,4,5-trisphosphate-3-kinase-A for motility of malignant transformed cells. Int J Cancer 2011;129:1300-9. http://www.ncbi.nlm.nih.gov/pubmed/21792881
  • Sieghart W, Wang X, Schmid K, Pinter M, König F, Bodingbauer M, Wrba F, Rasoul-Rockenschaub S, Peck-Radosavljevic M. Osteopontin expression predicts overall survival after liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria. J Hepatol. 201;54:89-97. http://www.ncbi.nlm.nih.gov/pubmed/20970216
  • Schmid K, Bago-Horvath Z, Variu S, Haitel A, Cejka D, Werzowa J, Berger M, Filipits M, Herberger B, Sieghart W. Dual inhibition of EGFR and mTOR pathway in small cell lung cancer. Br J Cancer 2010;103:622-8. http://www.ncbi.nlm.nih.gov/pubmed/20683448
  • Valencak J, Kittler H, Schmid K, Schreiber M, Raderer M, Gonzalez Inchaurraga M, Birner P, Pehamberger H. Prognostic relevance of hypoxia inducible factor-1 expression in patients with melanoma. Clin Exp Dermatol 2009;34:962-4. http://www.ncbi.nlm.nih.gov/pubmed/20055873
  • Lagler H, Sharif O, Haslinger I, Matt U, Stich K, Furtner T, Doninger B, Schmid K, Gattringer R, de Vos AF, Knapp. TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. J Immunol. 2009;1833:2027-36. http://www.ncbi.nlm.nih.gov/pubmed/19596984
  • Schmid K, Oehl Natalie, Wrba F, Pirker R, Pirker C, Filipits M. EGFR/KRAS/BRAF mutations in primary lung adenocarcinomas and corresponding loco-regional lymph node metastases. Clinical Cancer Research. 2009;15:4554-60. http://www.ncbi.nlm.nih.gov/pubmed/19584155
  • Herberger B, Berger W, Puhalla H, Schmid K, Novak S, Brandstetter A, Pirker C, Gruenberger T, Filipits M. Simultaneous blockade of the epidermal growth factor receptor/mammalian target of rapamycin pathway by epidermal growth factor receptor inhibitors and rapamycin results in reduced cell growth and survival in biliary tract cancer cells. Mol Cancer Ther. 2009 Jun;8:1547-56. http://www.ncbi.nlm.nih.gov/pubmed/19509244
  • Pinter M, Wichlas M, Schmid K, Plank C, Müller C, Wrba F, Peck-Radosavljevic M. Thalidomide in advanced hepatocellular carcinoma as antiangiogenic treatment approach: a phase I/II trial. Eur J Gastroenterol Hepatol. 2008;2010:1012-9. http://www.ncbi.nlm.nih.gov/pubmed/18787470
  • Schneider R, Gollackner B, Edel B, Schmid K, Wrba F, Tucek G, Walochnik J, Auer H. Development of a new PCR protocol for the detection of species and genotypes (strains) of Echinococcus in formalin-fixed, paraffin-embedded tissues. Int J Parasitol. 2008;38:1065-71. http://www.ncbi.nlm.nih.gov/pubmed/18177654
  • Filipits M, Haddad V, Schmid K, Huynh A, Dunant A, André F, Brambilla E, Stahel R, Pignon JP, Soria JC, Popper HH, Le Chevalier T, Pirker R. Multidrug resistance proteins do not predict benefit of adjuvant chemotherapy in patients with completely resected non-small cell lung cancer: International Adjuvant Lung Cancer Trial Biologic Program. Clin Cancer Res. 2007;13:3892-8. http://www.ncbi.nlm.nih.gov/pubmed/17606722
  • Filipits M, Pirker R, Dunant A, Lantuejoul S, Schmid K, Huynh A, Haddad V, André F, Stahel R, Pignon JP, Soria JC, Popper HH, Le Chevalier T, Brambilla E. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program. J Clin Oncol. 2007;25:2735-40. http://www.ncbi.nlm.nih.gov/pubmed/17602078
  • Bodingbauer M, Tamandl D, Schmid K, Plank C, Schima W, Gruenberger T. Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases. Br J Surg. 2007;94:1133-8. http://www.ncbi.nlm.nih.gov/pubmed/17514637
  • Mueller-Mang C, Grosse C, Schmid K, Stiebellehner L, Bankier AA. What every radiologist should know about idiopathic interstitial pneumonias. Radiographics. 2007;27:595-615. http://www.ncbi.nlm.nih.gov/pubmed/17495281
  • Sieghart W, Fuereder T, Schmid K, Cejka D, Werzowa J, Wrba F, Wang X, Gruber D, Rasoul-Rockenschaub S, Peck-Radosavljevic M, Wacheck V. Mammalian target of rapamycin pathway activity in hepatocellular carcinomas of patients undergoing liver transplantation. Transplantation. 2007;83:425-32. http://www.ncbi.nlm.nih.gov/pubmed/17318075
  • Müller-Mang C, Stiebellehner L, Schmid K, Bankier A. Idiopathic interstitial pneumonias: from classification to diagnostic work-up. Radiologe. 2007;47:384-92. http://www.ncbi.nlm.nih.gov/pubmed/17245606
  • Schmid K, Wang X, Haitel A, Sieghart W, Peck-Radosavljevic M, Bodingbauer M, Rasoul-Rockenschaub S, Wrba F. KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study. Virchows Arch. 2007;450:143-9. http://www.ncbi.nlm.nih.gov/pubmed/17245606
  • Schmid K, Angerstein N, Geleff S, Gschwendtner A. Quantitative nuclear texture features analysis confirms WHO classification 2004 for lung carcinomas. Mod Pathol. 2006 Mar;19(3):453-9. http://www.ncbi.nlm.nih.gov/pubmed/16462732
  • Sieghart W, Losert D, Strommer S, Cejka D, Schmid K, Rasoul-Rockenschaub S, Bodingbauer M, Crevenna R, Monia BP, Peck-Radosavljevic M, Wacheck V. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. J Hepatol. 2006;44:151-7. http://www.ncbi.nlm.nih.gov/pubmed/16462732
  • Schmid K, Birner P, Gravenhorst V, End A, Geleff S: Prognostic value of lymphatic and blood vessel invasion in neuroendocrine tumors of the lung. Am J Surg Pathol. 2005;29(3):324-8. http://www.ncbi.nlm.nih.gov/pubmed/15725800
  • Taghavi S, Marta GM, Lang G, Seebacher G, Winkler G, Schmid K, Klepetko Bronchial stump coverage with a pedicled pericardial flap: an effective method for prevention of postpneumonectomy bronchopleural fistula. Ann Thorac Surg. 2005;79:284-8. Review. http://www.ncbi.nlm.nih.gov/pubmed/15620959
  • Kasimir MT, Seebacher G, Jaksch P, Winkler G, Schmid K, Marta GM, Simon P, Klepetko W: Reverse cardiac remodelling in patients with primary pulmonary hypertension after isolated lung transplantation. Europ J Cardiothorac Surg. 2004;26:776-81. http://www.ncbi.nlm.nih.gov/pubmed/15450572
  • Schmid K, Wild T, Bolz M, Horvat R, Jurecka W, Zehetmayer M: Kaposi`s sarcoma of the conjunctiva leads to a diagnosis of acquired immunodeficiency syndrome. Acta Ophthal Scan 2003;81:411. http://www.ncbi.nlm.nih.gov/pubmed/12859274
  • Daxböck F, Brunner G, Popper H, Krause R, Schmid K, Krejs GJ, Wenisch C: A case of lung transplantation following mycoplasma pneumoniae infection. Eur J Clin Microbiol nfect Dis. 2002;2:318-22. http://www.ncbi.nlm.nih.gov/pubmed/12072947
  • Zoechbauer-Muller S, Filipits M, Rudas M, Brunner R, Krajnik G, Suchomel R, Schmid K, Pirker R: P-glycoprotein and MRP1 expression in axillary lymph node metastases of breast cancer patients. Anticancer Res. 2001;21:119-24. http://www.ncbi.nlm.nih.gov/pubmed/11299725
  • Losert H, Schmid K, Wilfing A, Winkler S, Staudinger T, Kletzmayr J, Burgmann H. Experiences with severe P. falciparum malaria in the intensive care unit. Intensive Care Med. 2000;26:195-201. http://www.ncbi.nlm.nih.gov/pubmed/10784308
  • Peck-Radosavljevic M, Prokesch R, Schmid K, Frossard M, Wichlas M, Gendo A, Gangl A, Madl C: Fulminant lethal tuberculous pneumnia (sepsis tuberculosis gravissima) with ARDS in a non-immuncompromised western European middle-aged man. Wien Klin Wochenschr. 1999;11(4):157-60. http://www.ncbi.nlm.nih.gov/pubmed/10192149

Kontaktiere mich!

Es ist Zeit, dich um deine Gesundheit zu kümmern! Alles was du tun musst, ist mir eine Nachricht zu schreiben.

Nutze das Kontaktformular direkt hier auf dieser Seite.